NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals
This is a contract result notice, not an open opportunity. Details from the official award data.
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals<br/><br/>Offer reference number: CM/PHR/22/5675<br/><br/>CM/PHR/22/5675/01 - NHS Framework Agreement for Branded Medicines – National Category Tender Lot 1.
Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/><br/>CM/PHR/22/5675/02 - NHS Framework Agreement for Branded Medicines – National Tender Lot 2.
Period of framework: 1 May 2023 to 30 April 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
What this notice demands of you
1 named, none in explicit obligation language. Each one is quoted from the notice.
NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals
Matched against the notice text, so this is a floor — the tender pack will demand things the notice never mentions. “Says must” means the quoted sentence itself used obligation language; anything ambiguous is left as a mention.
Make the case to bid
Reveal who to approach at NHS England, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- ocds-h6vhtk-0380b4
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 010254-2023
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
NHS England’s tender network